VALUE DRIVEN MEDICINE Trademark

Trademark Overview

On Monday, June 13, 2011, a trademark application was filed for VALUE DRIVEN MEDICINE with the United States Patent and Trademark Office. The USPTO has given the VALUE DRIVEN MEDICINE trademark a serial number of 85344501. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 7, 2023. This trademark is owned by Heritage Pharmaceuticals Inc.. The VALUE DRIVEN MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
value driven medicine

General Information

Serial Number85344501
Word MarkVALUE DRIVEN MEDICINE
Filing DateMonday, June 13, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 7, 2023
Registration Number4215016
Registration DateTuesday, September 25, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2011

Trademark Statements

Goods and ServicesFull line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
Disclaimer with Predetermined Text"MEDICINE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 7, 2023
Primary Code005
First Use Anywhere DateWednesday, August 31, 2011
First Use In Commerce DateWednesday, August 31, 2011

Trademark Owner History

Party NameHeritage Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837
Party NameHeritage Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837
Party NameHeritage Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdison, NJ 08837

Trademark Events

Event DateEvent Description
Friday, April 7, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, September 25, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 11, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, May 11, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 11, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 30, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, September 25, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 28, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 28, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 25, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 20, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, August 16, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 30, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, July 16, 2012USE AMENDMENT FILED
Friday, July 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 16, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, January 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 24, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 20, 2011ASSIGNED TO LIE
Tuesday, September 27, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 26, 2011EXAMINER'S AMENDMENT ENTERED
Monday, September 26, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 26, 2011EXAMINERS AMENDMENT E-MAILED
Monday, September 26, 2011EXAMINERS AMENDMENT -WRITTEN
Sunday, September 25, 2011ASSIGNED TO EXAMINER
Thursday, June 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2011NEW APPLICATION ENTERED

Related Keywords

medicine driven value anti antagonist thyroid receptor histamine ophthalmic progestin androgen proton pump